Innovations in Immunology

GeoVax is a clinical-stage biotechnology company developing human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease. 

 

Our current development programs are focused on preventive vaccines against COVID-19, hemorrhagic fever viruses (Ebola, Lassa, Marburg and Sudan), Zika Virus, and malaria, as well as therapeutic vaccines against multiple cancers.
Innovative Science
World Class Collaborators
Fighting Cancer
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
Copyright © GeoVax 2022. All Rights Reserved.

Search